Ditchcarbon
  • Customers
  1. Organizations
  2. Ginkgo
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 10 days ago

Ginkgo

Company website

Ginkgo Bioworks, often referred to simply as Ginkgo, is a pioneering biotechnology company headquartered in the United States. Founded in 2008, Ginkgo has established itself as a leader in the field of synthetic biology, focusing on designing custom microbes for a variety of applications across industries such as agriculture, pharmaceuticals, and food production. With major operational regions spanning North America and beyond, Ginkgo's innovative platform enables the rapid development of biological products. Their core offerings include engineered organisms that can produce valuable compounds, setting them apart through their unique approach to bioengineering. Notable achievements include significant partnerships and collaborations that have propelled Ginkgo to a prominent market position, making it a key player in the evolving landscape of biotechnology.

DitchCarbon Score

How does Ginkgo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Ginkgo's score of 25 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

Ginkgo's reported carbon emissions

In 2022, Ginkgo Bioworks, headquartered in the US, reported total carbon emissions of approximately 3,310,074 kg CO2e. This figure includes about 1,060,819 kg CO2e from Scope 1 emissions and approximately 2,254,255 kg CO2e from Scope 2 emissions. Notably, Ginkgo has not disclosed any Scope 3 emissions data. Despite the significant emissions reported, Ginkgo has not established specific reduction targets or climate pledges as part of their sustainability initiatives. The absence of such commitments suggests a need for further development in their climate strategy. Ginkgo Bioworks operates independently and does not inherit emissions data from a parent company, ensuring that their reported figures reflect their own operational impact. As the company continues to evolve, it may consider setting ambitious targets to align with industry standards and enhance its climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
1,060,819
Scope 2
2,254,255
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ginkgo's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ginkgo is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ginkgo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Biomerieux

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

BGI Genomics Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Cue Health Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Wuxi Biologics

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Senti Biosciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy